Radium-223, enzalutamide, and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD.
[25] The preferential metastatic sites in 316 patients with PC were bone (89.5% ... BM: Brain metastasis; CRPC: Castration-resistant prostate cancer; CT: Computed tomography; NA: Not assessed ...
Nov. 14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...
Further tests, such as CT scans and bone scans, may be performed to determine whether prostate ... the extent of metastasis, appearance under the microscope and response of the cancer to initial ...
Androgen deprivation is the mainstay of advanced prostate cancer treatment ... an α-emitter (radium-223), the bone resorption-targeting drug denosumab and an immunotherapy (sipuleucel-T).
Notably, too, these cases are defined by metastasis, meaning it has started to spread to other structures ... while CAT scan is typically best to assess if the cancer has spread to lymph nodes. Since ...
Nov. 8, 2024 — Prostate cancer is the second most common cancer in men worldwide. Researchers have investigated a new strategy for the development of treatment options that not only slow tumor ...
Once prostate cancer has spread, other treatments are required. To check for signs of metastasis in people who have already undergone surgery or radiation but whose prostate-specific antigen (PSA ...
Source: Getty Images ASTRO released a clinical practice guideline with evidence-based recommendations for palliative radiation therapy for symptomatic bone metastases. The American Society for ...